Contact us   |  

GenoMed4All & ERN-EuroBloodNet Educational program on Artificial Intelligence in hematology for an expert audience

The GenoMed4All & ERN-EuroBloodNet Educational Program has been conceived by GenoMed4All Educational Scientific/ Technical Committee. It is a European Online Interactive Educational Program on Artificial Intelligence and its applications in hematology targeting the public-at-large and aiming to increase awareness of the cutting-edge advances of Artificial Intelligence for the diagnosis, treatments and follow-up of three different rare haematological clinical domains. The growing role of Artificial Intelligence will be displayed in improving care and accelerating patient management via personalized medicine.

This program consists of a cycle of 6 webinars provided by key experts speakers on the application of Artificial Intelligence in the field of Rare Haematological Diseases. It will be conducted on the Zoom Platform starting on the 18th of September and finishing on the 23rd of October 2024. It will be held on Wednesday at 12.30 pm (CET). Each webinar is a live session where interaction between speakers and the public will be encouraged during the closing Q&A session. 

PROGRAM

GenoMed4All & ERN-EuroBloodNet Educational program on Artificial Intelligence in hematology for an expert audience will provide an overview of GenoMed4All's mission and relevant applications of Artificial Intelligence in biomedicine. Different aspects of those approaches will be tackled, starting from the precision medicine definition, problem solving approach and the use of multi-omics (Genomics, Metabolomics, Proteomics, Radiomics) in clinical research. The following use cases will be presented: Myelodysplastic syndromes (MDS), Sickle Cell disease (SCD) and Multiple myeloma (MM). Strategies for data standardization and cross-border linkage of repositories. Finally, it will be addressed the Artificial Intelligence multi-modal approaches for diagnosis, early risk assessment and disease progression prediction. Mentioned topics are divided into those 4 different sessions, as follows:

  • Introductory session (the road so far) 

      Date: 18th of September 12:30 pm - 2:00 pm CET

      Speaker: Federico Alvarez.

  • Standardization, bias and data quality - focus on trustworthy, clinically relevant AI. 

      Date: 25th of September 12:30 pm – 1:30 pm CET

      Speaker: Gastone Castellani.

  • Regulatory framework. 

      Date: 2nd of October 12:30 pm - 1:30 pm CET

      Speaker: Nathan Lea.

  • Use case MDS overview of results (both from a technical and clinical perspective) + specific onboarding requirements (e.g. minimal dataset) 

      Date: 9th of October 12:30 pm - 1:30 pm CET

      Speakers: Saverio D'Amico & Elisabetta Sauta.

  • Use case SCD overview of results (both from a technical and clinical perspective) + specific onboarding requirements (e.g. minimal dataset). 

      Date: 16th of October 12:30 pm - 1:30 pm CET

      Speakers: Eduard van Beers, Raffaella Colombatti & Mar Mañú Pereira.

  • Use case MM overview of results (both from a technical and clinical perspective) + specific onboarding requirements (e.g. minimal dataset).

      Date: 23rd of October 12:30 pm - 1:30 pm CET

      Speakers: Marina Martello.

 FULL PROGRAM REGISTRATION NOW OPEN!

Register to the full program
Past webinars

Upcoming webinars

Check below the upcoming webinars and register!

Introductory session (the road so far)

18/09/2024 12:30
Speakers: Federico Alvarez
Target: Patients, Health professionals, Patients organizations
Subnetworks: Lymphoid malignancies, Myeloid malignancies, Red blood cell defects
Disease Groups: Transversal
Register

Regulatory framework

02/10/2024 12:30
Speakers: Nathan Lea
Target: Patients, Health professionals, Patients organizations
Subnetworks: Lymphoid malignancies, Myeloid malignancies, Red blood cell defects
Disease Groups: Transversal
Register